Scientific Conference - A Broad-Spectrum Antipsychotic for the Treatment of Schizophrenia: Pharmacology, Efficacy, and Safety
In order to provide more new perspectives in the approach and treatment of schizophrenia, this afternoon on November 12, 2022, Gedeon Richter Group organized the Scientific Conference: "A Broad-Spectrum Antipsychotic for the Treatment of Schizophrenia: Pharmacology, Efficacy, and Safety" at Pullman Hotel, Ha Noi.
The seminar had the participation of representatives of Bepharco - exclusive partner to deploy products in Vietnam market and leading national and international psychiatrists:
- Chairman: Assoc.Prof Ph.D Dr. Nguyen Van Tuan: Director of the National Institute of Mental Health, Head of the Department of Psychiatry, Hanoi Medical University, Vice President - cum Secretary General of the Vietnam Psychiatric Association.
- Senior Reporter: Prof Ph.D Dr Cao Tien Duc: Vice President of Vietnam Psychiatric Association, Former Head of Psychiatry Department - Military Medical Practitioner, Former Head of Psychiatry Department - Military Medical Hospital 103.
- Reporter: Ph.D Dr Dang Duy Thanh: Director of Khanh Hoa Psychiatric Hospital
- Reporter Dr. Ágota Barabássy MD: Head of the psychoactive drug research group - Gedeon Richter Group Hungary.
Through the workshop, doctors and representatives from Gedeon Richter Group provided information on Cariprazine - A Broad-Spectrum Antipsychotic for the Treatment of Schizophrenia: Pharmacology, Efficacy, and Safety; The unique mechanism of action and dosage of cariprazine.
The conference was held successfully and effectively. At the same time, this is also an opportunity to help doctors update useful knowledge in accessing, examining and treating schizophrenia and symptoms of psychosis.